Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vascular endothelial growth factor, a multifunctional polypeptide

C C Stephan1, T A Brock

  • 1Department of Pharmacology, Texas Biotechnology Corporation Houston 77030, USA. cstephan@tbc.com

Puerto Rico Health Sciences Journal
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of DNA2 nuclease as a therapeutic strategy targeting replication stress in cancer cells.

Oncogenesis·2017
Same author

Growth factor antagonists for the treatment of diabetic vascular complications.

Expert opinion on investigational drugs·2005
Same author

Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension.

Expert opinion on investigational drugs·2002
Same author

Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor.

The Journal of biological chemistry·2001
Same author

TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets.

Pediatric research·2001
Same author

Acyl substitution at the ortho position of anilides enhances oral bioavailability of thiophene sulfonamides: TBC3214, an ETA selective endothelin antagonist.

Journal of medicinal chemistry·2001

Angiogenesis, the formation of new blood vessels, is crucial for development and disease. Understanding vascular endothelial growth factor (VEGF) and its receptors is key to controlling these processes.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Physiology

Background:

  • Angiogenesis is a complex process of new blood vessel formation from existing ones.
  • It is vital in development, healing, and reproduction, but also in diseases like cancer and arthritis.
  • The molecular mechanisms are being actively researched.

Purpose of the Study:

  • To summarize current knowledge on vascular endothelial growth factor (VEGF) and its receptors.
  • To review VEGF receptor biology and signal transduction in endothelial cells.
  • To provide an overview of the factors controlling angiogenesis.

Main Methods:

  • Literature review of VEGF and VEGF receptor biology.
  • Summary of signal transduction pathways.
  • Discussion of the role of VEGF in physiological and pathophysiological processes.

Related Experiment Videos

Main Results:

  • VEGF, initially identified as vascular permeability factor (VPF), promotes endothelial cell proliferation.
  • Multiple VEGF receptor subtypes contribute to its diverse biological actions.
  • VEGF signaling is central to both normal and abnormal angiogenesis.

Conclusions:

  • Elucidating VEGF and its receptor mechanisms is fundamental to understanding blood vessel development and diseases.
  • VEGF plays a critical role in both physiological and pathological angiogenesis.
  • Further research into VEGF signaling pathways is essential for therapeutic interventions.